Catalent stops production at French plant, brings in law enforcement after it twice detects tampering

Eric Palmer

U.S.-based has halted at a drug manufacturing facility in France at the request of regulators several incidents in which it appears someone within the purposely mixed the wrong capsules into batches. The company said it is working with law and regulators to find out what happened.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS